Actively Recruiting
Pelvic Cancer Registry for Online Adapted Radiotherapy
Led by University Medical Center Goettingen · Updated on 2024-02-08
846
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective registry-based trial will include patients with pelvic or thoracic tumors with an indication for radiotherapy treated with oART or IGRT. For the primary endpoint and the secondary clinical endpoints, the trial will compare oART versus IGRT, for technical endpoints the trial will compare the real oART scenario with two virtual (hypothetical) control scenarios. Primary endpoint: * 10% reduction in the rate of acute radiotherapy related toxicity (≥ CTCAE II°, v5.0) using oART Secondary endpoints: * Clinical endpoints: Tumor control, late toxicities compared to conventional irradiated patients, quality of life and patient-reported outcomes * Technical endpoints: Target volume, target coverage, dose to organs at risk, anatomical variability score
CONDITIONS
Official Title
Pelvic Cancer Registry for Online Adapted Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with pelvic or thoracic tumors with an indication for radiotherapy
- Patient information and declaration of consent
- Patients age 65 18 years
You will not qualify if you...
- Prior radiotherapy in affected site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center, Departement of Radiation Oncology
Göttingen, Germany
Actively Recruiting
Research Team
L
Laura Anna Fischer
CONTACT
R
Rami El Shafie
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here